Figure 4.
Figure 4. Antigen-specific immune responses in patients with AML exhibiting ecto-CRT+ vs ecto-CRT−blasts. (A-B) Representative dot plots (A) and quantitative data (B) of IFN-γ–secreting CD45+CD3+CD4+ T cells and CD45+CD3+CD8+ T cells from 10 HD or 15 CRTHi vs 15 CRTLo patients with AML before induction chemotherapy (Prior, B) and at reestablishment of normal hematopoiesis (Recovery, A-B), upon exposure of the corresponding PBMCs to peptide mixture spanning BIRC5, CCNB1, PRAME, or WT1. Box plots: lower quartile, median, upper quartile; whiskers, minimum value, maximum value.

Antigen-specific immune responses in patients with AML exhibiting ecto-CRT+vs ecto-CRTblasts. (A-B) Representative dot plots (A) and quantitative data (B) of IFN-γ–secreting CD45+CD3+CD4+ T cells and CD45+CD3+CD8+ T cells from 10 HD or 15 CRTHi vs 15 CRTLo patients with AML before induction chemotherapy (Prior, B) and at reestablishment of normal hematopoiesis (Recovery, A-B), upon exposure of the corresponding PBMCs to peptide mixture spanning BIRC5, CCNB1, PRAME, or WT1. Box plots: lower quartile, median, upper quartile; whiskers, minimum value, maximum value.

Close Modal

or Create an Account

Close Modal
Close Modal